More and more, we hear about increasing incidences of cancer, growing awareness regarding the benefits of 3D cell culture, rising regulatory approvals for cell culture-based vaccines, funding for cell-based research, and technological advancements.
On the other hand, one can also observe that, high cost of cell biology research and lack
of infrastructure for cell-based research in emerging economies are the major
factors restraining the growth of this market.
According to Research and Markets, the high growth potential in the Asia-Pacific region will be a game-changer
of the global 3D Cell Culture industry.
The firm
reveals that, the global 3D cell culture market size is expected to reach USD 1345.2
million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%.
For those who are unfamiliar, the global 3D cell culture market can be
segmented based on Technology (Scaffold Based,
Scaffold Free), Application (Cancer
Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography.
Many experts in 3D cell culture market agree that the biotechnology & pharmaceutical industries segment is expected to account for the largest share of the market in 2016.
Many experts in 3D cell culture market agree that the biotechnology & pharmaceutical industries segment is expected to account for the largest share of the market in 2016.
Research and Markets reveals that, geographically, the 3D cell culture market is dominated by North America, followed by Europe, Asia-Pacific, and Rest of the World (RoW).
Growth in the North American segment is primarily driven by rising
incidences of cancer, increasing government support in the form of grants and
funding, expanding bio pharmaceutical industry, and launch of new products in
the market.
Among major players in this market include, we have: 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd, (a subsidiary of ReproCELL) (U.K.), and others.
Among major players in this market include, we have: 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd, (a subsidiary of ReproCELL) (U.K.), and others.